Adjustments in Drug Coverage Criteria in Health Plans Based on New Evidence
However, researchers found that only a small percentage of plans use available real-world evidence studies and economic evaluations in their coverage policies.
Supporting the Next Era of Independent Pharmacies in the US & Abroad
The future of independent pharmacy requires the combination of what makes independent pharmacy special and the digital landscape found elsewhere in retail.
Program for Safer Opioid Supply Shows Positive Results
Positive effects emerge when patients get medical care, avoid deadly fentanyl-laced street drugs.
News Roundup: September 19 to September 23
Your weekly roundup of the latest news from Drug Topics®.
Advocating for Increased Access to Medication for Treating Opioid Use Disorder
The National Commission on Correctional Health Care and 166 other national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.
Housing, Food Insecurity Can Be Caused By Medical Debt
Hospitalization, disability, having private high-deductible, Medicare Advantage, or no coverage were risk factors associated with medical debt.
Rukobia Works for Some AIDS Patients, According to New Research
ViiV Healthcare reports long-term positive results for its drug, Rukobia (fostemsavir).
Wegovy Represents New Weight Loss Drug Story
The harm caused by weight-loss drugs have overwhelmed any benefit they may have. The repurposed diabetes drugs like Wegovy (semaglutide) have a strong safety profile.
News Roundup: September 11 to September 16
News Roundup: September 5 to September 9
News Roundup: August 29 to September 2
Prescription Drug Costs a Worry for Consumers
Survey participants said their drug costs have gone up and almost a third had trouble paying for food and housing because of high drug costs.
Another Lot of Propofol Recalled
This recall of propofol because of particulates seen in vials follows a previous one in July 2022.
August Month in Review: Top Stories on Drug Topics®
Take a look back at our most popular news from August 2022.
Inflation Reduction Act Benefits Medicare Patients
Medicare users will see prescription drug pricing reform thanks to the Inflation Reduction Act.
News Roundup: August 22 to August 26
Plaque Psoriasis Treatment Gets Even More Company
Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.
What's the Future of the 340B Program?
Drug manufacturers are rejecting the program’s blanket discounts involving contract pharmacies. A flurry of litigation has ensued.
Immune Health Supplements May Not Be What They Seem
Consumers are purchasing dietary supplements that support or boost the immune system like never before.
Examining OUD Treatment Strategies
Opioid use disorder—how can we battle the epidemic of overdoses?
News Roundup: August 15 to August 19
How Supplements and Diet Can Impact Psoriasis
Examining the results of a study examining the role of supplements and diets in managing psoriasis.
Undiagnosed Diabetes May Not Be as Common as Thought
Overall numbers may be lower, but the obese, racial/ethnic minorities, and those without health care access have higher numbers of undiagnosed diabetes
Breaking: FDA Finalizes Rule Allowing OTC Access to Hearing Aids
The rule change could save money for millions.
Nearly 40% of Americans Say Inflation Has Impacted Health Care
Patients are either skipping care completely, cutting costs elsewhere, or borrowing money to pay for health care
News Roundup: August 8 to August 12
Vivjoa Approved for Recurrent Vulvovaginal Candidiasis
Oteseconazole is a treatment option for those living with a previously unmet medical need.
News Roundup: August 1 to August 5
Rate of People Without Health Insurance Hits Record Low
More people getting health coverage, but 26.4 million still don’t have it.
A New CE Session to Check Out
A new CE opportunity that's available on-demand.
